Catalyst Wire Dossier Catalyst Wire Dossier

KABIVEN

· Fresenius Kabi USA, LLC
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for KABIVEN, covering 2014-08-25 to 2025-07-24. Get the full timeline:

Most recent: FDA Approved: KABIVEN — Supplemental Application (Fresenius Kabi USA, LLC)

See pricing